- Health Spotlight's Amyotrophic Lateral Sclerosis Insights
- Posts
- Weekly Spotlight - 21.11.24
Weekly Spotlight - 21.11.24
Young Caregivers' Dedicated Support and Innovative Treatment Development
Community |
Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters! |
Latest News |
Young Caregivers: The Journey of Caring for Loved Ones with ALS |
The article highlights the challenges and dedication of young caregivers who are caring for family members with ALS. It shares personal stories of these caregivers, emphasizing their emotional struggles, financial burdens, and the need for support and resources to help them manage their roles effectively. |
Trace Neuroscience Initiates Development of UNC13A Treatment for ALS Patients |
Trace Neuroscience is developing a new treatment for ALS, focusing on the UNC13A gene. This gene is linked to the progression of ALS, and the treatment aims to slow down or halt the disease's advancement by targeting this genetic factor. The goal is to improve the quality of life for those with ALS. |
Biogen and Trace Neuroscience Collaborate on ALS Antisense Therapy Research |
Biogen and Trace Neuroscience are collaborating on a new approach to treat ALS using antisense therapy, a genetic medicine that targets specific genetic mutations. This research aims to develop a treatment, known as Qalsody, which could potentially slow or halt the progression of ALS. |
The article discusses a grant from the ALS Association (ALSA) to support research on a new therapeutic approach for ALS. The funding aims to develop a treatment that targets a specific protein involved in the disease, potentially slowing its progression and improving patient outcomes. This research could offer new hope for those living with ALS. |
Health Spotlight’s Amyotrophic Lateral Sclerosis is a Contentive publication in the Healthcare division